These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33402095)

  • 61. Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana.
    Adu E; Ampadu E; Acheampong D
    Ghana Med J; 2011 Mar; 45(1):4-9. PubMed ID: 21572818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo.
    Maman I; Tchacondo T; Kere AB; Beissner M; Badziklou K; Tedihou E; Nyaku E; Amekuse K; Wiedemann FX; Karou DS; Bretzel G
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006455. PubMed ID: 29782522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
    Guarner J
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343539
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.
    Sugawara M; Ishii N; Nakanaga K; Suzuki K; Umebayashi Y; Makigami K; Aihara M
    J Dermatol; 2015 Jun; 42(6):588-95. PubMed ID: 25809502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
    Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH
    PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
    Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
    Converse PJ; Nuermberger EL; Almeida DV; Grosset JH
    Future Microbiol; 2011 Oct; 6(10):1185-98. PubMed ID: 22004037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of BU-HIV co-infection.
    O'Brien DP; Ford N; Vitoria M; Christinet V; Comte E; Calmy A; Stienstra Y; Eholie S; Asiedu K
    Trop Med Int Health; 2014 Sep; 19(9):1040-7. PubMed ID: 24946829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Buruli ulcer in southern Côte D'ivoire: dynamic schemes of perception and interpretation of modes of transmission.
    Konan DO; Mosi L; Fokou G; Dassi C; Narh CA; Quaye C; Saric J; Abe NN; Bonfoh B
    J Biosoc Sci; 2019 Jul; 51(4):520-533. PubMed ID: 30376901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.
    Williamson HR; Benbow ME; Campbell LP; Johnson CR; Sopoh G; Barogui Y; Merritt RW; Small PL
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1506. PubMed ID: 22303498
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
    Sarfo FS; Phillips RO; Zhang J; Abass MK; Abotsi J; Amoako YA; Adu-Sarkodie Y; Robinson C; Wansbrough-Jones MH
    BMC Infect Dis; 2014 Apr; 14():202. PubMed ID: 24731247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.
    Omansen TF; Almeida D; Converse PJ; Li SY; Lee J; Stienstra Y; van der Werf T; Grosset JH; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The co-infection of Buruli ulcer and cutaneous leishmaniasis in Sudanese patient: An association by choice or by chance?
    Nail AMA; Tonga RA; Salih HM; Abuzeid N; Ahmed MH
    J Infect Public Health; 2020 Aug; 13(8):1184-1186. PubMed ID: 32359927
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Warryn L; Pluschke G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0087021. PubMed ID: 34662181
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d'Ivoire: A Case-Control Study.
    N'krumah RT; Koné B; Tiembre I; Cissé G; Pluschke G; Tanner M; Utzinger J
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004327. PubMed ID: 26745723
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
    Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease.
    Warryn L; Pluschke G
    Chimia (Aarau); 2023 Sep; 77(9):577-581. PubMed ID: 38047833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Susceptibility Profiles of
    Owusu E; Newman MJ; Kotey NK; Akumwena A; Bannerman E
    Int J Microbiol; 2016; 2016():8304524. PubMed ID: 28070190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.